Search results
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 2 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 23 hours agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 1 day agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Penn researchers create avian flu vaccine using COVID shot technique
The Patriot-News· 3 hours agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 2 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoShares of Novavax which makes a Covid-19 vaccine, were up 6.3%. Even vaccine stalwarts like GSK and...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 3 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 1 day agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 2 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 6 hours agoShares of vaccine stocks Moderna (MRNA 0.85%), Novavax (NVAX 3.17%), and BioNTech SE (BNTX -2.99%)...